IMbrave050 Trial Design: Adjuvant Therapy for Early-Stage Hepatocellular Carcinoma | Docwire News
Drs. Finn and Yopp discuss the IMbrave050 study for early-stage HCC, including the trial design, results, and implications.
Related Articles
Joe Rogan stunned as Mel Gibson reveals how friends cured their cancer
On the latest episode of the Joe Rogan Experience, actor Mel Gibson left the veteran podcaster shocked by the controversial way his friends claimed to…
讛讻讞 诇讛诪砖讬讱 | 砖讬专 讛住讟讬拽专讬诐 讛讬砖专讗诇讬 砖诇 讛讞讬讬诇讬诐 The Power to Continue | Soldiers of Israel Stickers
砖诇讜诐, 砖诪讬 注讬诇诐 讬砖专讗诇 讘专 砖诇讜诐, 讜讻转讘转讬 砖讬专 ‘讛讻讞 诇讛诪砖讬讱’, 诪诪讬诇讜转讬讛诐 砖诇 讞讬讬诇讬 爪讛”诇 讙讬讘讜专讬诐, 讗砖专 诪住专讜 谞驻砖诐 诇诪讜转 诇讛讙谞讛 注诇 讛注诐 讜讛诪讜诇讚转 讘诪诇讞诪转 ‘讞专讘讜转…
STRATA Study: The Role of Cxbladder Triage in Reducing Cystoscopy Burden | GU Oncology Now
Dr. Lotan describes the design and key findings of the STRATA trial using Cxbladder Triage for patients with microhematuria.
Reaching for the Holy Grail in Myelofibrosis With Imetelstat Combinations | Blood Cancers Today
In an exclusive interview with Blood Cancers Today, John Mascarenhas, MD discussed the development of the imetelstat for the treatment of myelofibrosis.
Challenges in Cardiomyopathy Gene Therapy Clinical Trial Design:
AbstractGene therapy has emerged as a possible treatment for progressive, debilitating Mendelian cardiomyopathies with limited therapeutic options. This paper arises from discussions at the 2023…
TCTMD – tctmd.com
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
Survey Data Reveal Changes in Global Progress in Kidney Disease Care | Docwire News
A global review noted changes in kidney care delivery but revealed gaps in access to kidney replacement therapies.
Structural Heart Imaging Using 3-Dimensional Intracardiac Echocardiography: JACC: Cardiovascular Imaging Position Statement
Abstract3-dimensional (3D) intracardiac echocardiography (ICE) is emerging as a promising complement and potential alternative to transesophageal echocardiography for imaging guidance in structural…
Early and Late Outcomes With the Absorb Bioresorbable Vascular Scaffold: Final Report From the ABSORB Clinical Trial Program
AbstractBackgroundThe risk-benefit ratio of the Absorb bioresorbable vascular scaffold (BVS) may vary before and after 3 years, the time point of complete bioresorption of the…
Transfusions Have Major Impact on Quality of Life for Patients With MF | Blood Cancers Today
Patients with MF experience significant burdens from anemia and transfusions, which negatively affect daily activities, emotional well-being, and physical health, research shows.